rs61750251

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BS2BA1

This summary comes from the ClinGen Evidence Repository: The allele frequency of the p.Ala280= variant in MECP2 (NM_004992) is 0.034% in European (Non-Finnish) sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The p.Ala280= variant is observed in at least 2 unaffected individuals (PMID 11469283, PMID 20479760) (BS2). In summary the p.Ala280= variant in MECP2 is classified as Benign for Rett syndrome disorder based on the ACMG/AMP criteria (BA1, BS2). LINK:https://erepo.genome.network/evrepo/ui/classification/CA199315/MONDO:0010726/016

Frequency

Genomes: 𝑓 0.00023 ( 0 hom., 5 hem., cov: 23)
Exomes 𝑓: 0.00035 ( 0 hom. 120 hem. )

Consequence

MECP2
NM_001110792.2 synonymous

Scores

2

Clinical Significance

Benign reviewed by expert panel B:9

Conservation

PhyloP100: -2.11

Publications

1 publications found
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
MECP2 Gene-Disease associations (from GenCC):
  • chromosome Xq28 duplication syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • Rett syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet, G2P
  • severe neonatal-onset encephalopathy with microcephaly
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • syndromic X-linked intellectual disability Lubs type
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked intellectual disability-psychosis-macroorchidism syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • systemic lupus erythematosus
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BS2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001110792.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MECP2
NM_001110792.2
MANE Select
c.876C>Tp.Ala292Ala
synonymous
Exon 3 of 3NP_001104262.1A0A140VKC4
MECP2
NM_004992.4
MANE Plus Clinical
c.840C>Tp.Ala280Ala
synonymous
Exon 4 of 4NP_004983.1D3YJ43
MECP2
NM_001316337.2
c.561C>Tp.Ala187Ala
synonymous
Exon 5 of 5NP_001303266.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MECP2
ENST00000453960.7
TSL:1 MANE Select
c.876C>Tp.Ala292Ala
synonymous
Exon 3 of 3ENSP00000395535.2P51608-2
MECP2
ENST00000303391.11
TSL:1 MANE Plus Clinical
c.840C>Tp.Ala280Ala
synonymous
Exon 4 of 4ENSP00000301948.6P51608-1
MECP2
ENST00000630151.3
TSL:5
c.840C>Tp.Ala280Ala
synonymous
Exon 4 of 4ENSP00000486089.2P51608-1

Frequencies

GnomAD3 genomes
AF:
0.000232
AC:
26
AN:
111991
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000162
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000281
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00110
Gnomad FIN
AF:
0.000165
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000245
Gnomad OTH
AF:
0.000663
GnomAD2 exomes
AF:
0.000254
AC:
46
AN:
181066
AF XY:
0.000149
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000183
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000726
Gnomad FIN exome
AF:
0.000314
Gnomad NFE exome
AF:
0.000335
Gnomad OTH exome
AF:
0.000448
GnomAD4 exome
AF:
0.000348
AC:
382
AN:
1097907
Hom.:
0
Cov.:
35
AF XY:
0.000330
AC XY:
120
AN XY:
363367
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26400
American (AMR)
AF:
0.000114
AC:
4
AN:
35203
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19386
East Asian (EAS)
AF:
0.0000331
AC:
1
AN:
30206
South Asian (SAS)
AF:
0.000369
AC:
20
AN:
54144
European-Finnish (FIN)
AF:
0.000373
AC:
15
AN:
40249
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4136
European-Non Finnish (NFE)
AF:
0.000394
AC:
332
AN:
842116
Other (OTH)
AF:
0.000195
AC:
9
AN:
46067
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
17
34
50
67
84
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000232
AC:
26
AN:
112043
Hom.:
0
Cov.:
23
AF XY:
0.000146
AC XY:
5
AN XY:
34201
show subpopulations
African (AFR)
AF:
0.000162
AC:
5
AN:
30862
American (AMR)
AF:
0.000280
AC:
3
AN:
10706
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2645
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3543
South Asian (SAS)
AF:
0.00111
AC:
3
AN:
2709
European-Finnish (FIN)
AF:
0.000165
AC:
1
AN:
6068
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.000245
AC:
13
AN:
53081
Other (OTH)
AF:
0.000654
AC:
1
AN:
1528
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000255
Hom.:
2
Bravo
AF:
0.000283
EpiCase
AF:
0.000545
EpiControl
AF:
0.000415

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
Rett syndrome (2)
-
-
1
Inborn genetic diseases (1)
-
-
1
MECP2-related disorder (1)
-
-
1
not provided (1)
-
-
1
Severe neonatal-onset encephalopathy with microcephaly (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.0060
DANN
Benign
0.71
PhyloP100
-2.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61750251; hg19: chrX-153296439; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.